These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 35397719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.
    Puéchal X, Iudici M, Perrodeau E, Bonnotte B, Lifermann F, Le Gallou T, Karras A, Blanchard-Delaunay C, Quéméneur T, Aouba A, Aumaître O, Cottin V, Hamidou M, Ruivard M, Cohen P, Mouthon L, Guillevin L, Ravaud P, Porcher R, Terrier B, French Vasculitis Study Group.
    JAMA Netw Open; 2022 Nov 01; 5(11):e2243799. PubMed ID: 36441554
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.
    Yoo J, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW.
    Yonsei Med J; 2018 May 01; 59(3):397-405. PubMed ID: 29611402
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U, RAVE-ITN Research Group.
    Ann Rheum Dis; 2016 Jun 01; 75(6):1166-9. PubMed ID: 26621483
    [Abstract] [Full Text] [Related]

  • 6. BVAS version 3 and BVAS/GPA: standing on the same line?
    Ahn SS, Ha JW, Park YB, Lee SW.
    Clin Rheumatol; 2022 Nov 01; 41(11):3429-3437. PubMed ID: 35804274
    [Abstract] [Full Text] [Related]

  • 7. Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual.
    Delvino P, Sardanelli F, Monti S, Cohen P, Puéchal X, Mouthon L, Montecucco C, Guillevin L, Terrier B.
    Arthritis Care Res (Hoboken); 2023 May 01; 75(5):1158-1165. PubMed ID: 35604889
    [Abstract] [Full Text] [Related]

  • 8. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS).
    Ann Rheum Dis; 2015 Jun 01; 74(6):1178-82. PubMed ID: 25739829
    [Abstract] [Full Text] [Related]

  • 9. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H, Lee SM, Manno RL, Seo P, Geetha D.
    Semin Arthritis Rheum; 2015 Aug 01; 45(1):67-9. PubMed ID: 25796088
    [Abstract] [Full Text] [Related]

  • 10. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
    Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L, French Vasculitis Study Group.
    Ann Rheum Dis; 2018 Aug 01; 77(8):1143-1149. PubMed ID: 29695500
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Aug 01; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 12. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA.
    Rheumatology (Oxford); 2017 Nov 01; 56(11):1894-1901. PubMed ID: 28977502
    [Abstract] [Full Text] [Related]

  • 13. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J, Kim HJ, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW.
    Clin Exp Rheumatol; 2017 Nov 01; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
    Teixeira V, Mohammad AJ, Jones RB, Smith R, Jayne D.
    RMD Open; 2019 Nov 01; 5(1):e000905. PubMed ID: 31245051
    [Abstract] [Full Text] [Related]

  • 15. Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis-a real-life experience.
    Mittal S, Naidu GSRSNK, Jha S, Rathi M, Nada R, Minz RW, Sharma K, Dhir V, Jain S, Sharma A.
    Clin Rheumatol; 2021 Feb 01; 40(2):645-651. PubMed ID: 32656662
    [Abstract] [Full Text] [Related]

  • 16. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH, Wright MN, Herrmann K, Laudien M, Nölle B, Reinhold-Keller E, Bremer JP, Moosig F, Holle JU.
    Arthritis Rheumatol; 2016 Dec 01; 68(12):2953-2963. PubMed ID: 27333332
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
    Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L, French Vasculitis Study Group.
    Ann Rheum Dis; 2018 Aug 01; 77(8):1150-1156. PubMed ID: 29724729
    [Abstract] [Full Text] [Related]

  • 18. How best to manage relapse and remission in ANCA-associated vasculitis.
    Puéchal X, Guillevin L.
    Expert Rev Clin Immunol; 2022 Nov 01; 18(11):1135-1143. PubMed ID: 36102147
    [Abstract] [Full Text] [Related]

  • 19. The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
    Pyo JY, Lee LE, Ahn SS, Song JJ, Park YB, Lee SW.
    Yonsei Med J; 2021 Jun 01; 62(6):494-502. PubMed ID: 34027636
    [Abstract] [Full Text] [Related]

  • 20. Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
    Yoon T, Ha JW, Ko E, Song JJ, Park YB, Ahn SS, Lee SW.
    Yonsei Med J; 2023 Oct 01; 64(10):604-611. PubMed ID: 37727919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.